This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Heggen, J.
Right arrow Articles by Yeager, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heggen, J.
Right arrow Articles by Yeager, A. M.
Related Collections
Right arrow Respiratory Tract
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

PEDIATRICS Vol. 109 No. 5 May 2002, pp. 965-971


EXPERIENCE AND REASON

Diffuse Alveolar Hemorrhage in Pediatric Hematopoietic Cell Transplant Patients

Objective. Diffuse alveolar hemorrhage (DAH) is defined as a syndrome of hypoxia, dyspnea, infiltrates on chest radiograph, and bloody fluid on successive bronchoalveolar lavages without apparent infection. Minimal experience has been reported with DAH after hematopoietic cell transplant (HCT) in children. We reviewed the incidence, management and outcome of DAH in a pediatric HCT population.

Methods. Retrospective review of 138 patients undergoing allogeneic (n = 89) or autologous (n = 49) HCT at a referral children’s medical center between January 1996 and April 2000.

Results. Seven (5.1%) of 138 patients met criteria for DAH; all were allogeneic recipients. Mean age of DAH patients was 11 years (range: 1.4–15.2). Median onset of DAH following HCT was day 24 (range: 10–50), median day of engraftment day 20 and white blood cell count 0.54 x 109/L (range: < 0.1–7.03), with no difference between survivors and nonsurvivors. All patients developed clinical respiratory failure and 6 required intubation, with PaO2/fraction of inspired oxygen <200. Patients were intubated a median of 12 days (range: 1–75). All patients experienced >1 episode of bleeding and 3 patients required reintubation after successful extubation resulting from recurrent DAH. Bronchoalveolar lavage fluid cultures were negative for viruses, bacteria and fungi. All DAH patients received steroids. Three patients died with progressive pulmonary failure and other organ system involvement. Four of 7 DAH patients (57%) survived to discharge, but 3 died from disease relapse at days 116, 138, and 273 post-HCT.

Conclusion. DAH occurred more frequently in allogeneic HCT recipients compared with autologous recipients. Onset of DAH coincided closely with white blood cell engraftment. Although associated with significant respiratory failure and need for mechanical ventilation, HCT patients can survive DAH.

Judith Heggen, DO*, Carla West, MD{ddagger}, Ellen Olson, CPNP{ddagger}, Thomas Olson, MD{ddagger}, Gerald Teague, MD§, James Fortenberry, MD and Andrew M. Yeager, MD

* Department of Pediatrics
Division of Critical Care,
Emory University School of Medicine
Atlanta, GA 30322
{ddagger} Department of Pediatrics
Division ofHematology/Oncology,
Emory University School of Medicine
Atlanta, GA 30322
§ Department of Pediatrics
Division of Pulmonary
Emory University School of Medicine
Atlanta, GA 30322
Division of Critical Care
Children’s Healthcare of Atlanta at Egleston
Atlanta, GA 30322
University of Pittsburgh Cancer Institute
Pittsburgh, PA 15213

-->

Key Words: bone marrow transplant • pulmonary hemorrhage • respiratory failure • pediatric • bronchoalveolar lavage

Abbreviations: DAH, diffuse alveolar hemorrhage • BAL, bronchoalveolar lavage • CXR, chest radiograph • HCT, hematopoietic cell transplant • BMT, bone marrow transplant • GVHD, graft-versus-host disease • WBC, white blood cell • FIO2, fraction of inspired oxygen • AML, acute myeloblastic leukemia


Received for publication Jul 19, 2001; Accepted Nov 21, 2001.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
RadiologyHome page
C. L. Hollingsworth, D. P. Frush, J. Kurtzburg, and V. K. Prasad
Pediatric Hematopoietic Stem Cell Transplantation and the Role of Imaging
Radiology, August 1, 2008; 248(2): 348 - 365.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
R. Ben-Abraham, G. Paret, R. Cohen, O. Szold, G. Cividalli, A. Toren, and A. Nagler
Diffuse Alveolar Hemorrhage Following Allogeneic Bone Marrow Transplantation in Children
Chest, August 1, 2003; 124(2): 660 - 664.
[Abstract] [Full Text] [PDF]